Published in Cell Cycle on March 24, 2008
Cancer genes and the pathways they control. Nat Med (2004) 24.22
Cancer cell cycles. Science (1996) 21.29
Mdm2 promotes the rapid degradation of p53. Nature (1997) 21.26
A global map of p53 transcription-factor binding sites in the human genome. Cell (2006) 20.65
Regulation of p53 stability by Mdm2. Nature (1997) 18.20
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell (1992) 16.53
The p53-mdm-2 autoregulatory feedback loop. Genes Dev (1993) 11.19
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett (1997) 11.19
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature (1995) 8.68
Signaling to p53: breaking the MDM2-p53 circuit. Cell (1998) 8.63
The RB and p53 pathways in cancer. Cancer Cell (2002) 8.02
mdm2 expression is induced by wild type p53 activity. EMBO J (1993) 8.01
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature (1993) 7.90
Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res (1999) 7.82
Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem (2000) 6.92
Tumor surveillance via the ARF-p53 pathway. Genes Dev (1998) 5.11
XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks. Mol Cell (2007) 4.93
The MDM2 gene amplification database. Nucleic Acids Res (1998) 4.64
The ARF/p53 pathway. Curr Opin Genet Dev (2000) 4.13
Functions of the MDM2 oncoprotein. Cell Mol Life Sci (1999) 3.35
Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene (1993) 3.08
MDM2 is a central node in the p53 pathway: 12 years and counting. Curr Cancer Drug Targets (2005) 3.04
Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res (1994) 2.98
Steady states and oscillations in the p53/Mdm2 network. Cell Cycle (2005) 2.45
Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation. Cancer Cell (2007) 2.42
Cardiac actin is the major actin gene product in skeletal muscle cell differentiation in vitro. Mol Cell Biol (1984) 2.33
p53: guardian of the genome and policeman of the oncogenes. Cell Cycle (2007) 2.23
A functional p53-responsive intronic promoter is contained within the human mdm2 gene. Nucleic Acids Res (1995) 2.23
Dual-site regulation of MDM2 E3-ubiquitin ligase activity. Mol Cell (2006) 2.09
Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis. Proc Natl Acad Sci U S A (1998) 2.00
Mdm2 association with p53 targets its ubiquitination. Oncogene (1998) 1.94
Pocket protein complexes are recruited to distinct targets in quiescent and proliferating cells. Mol Cell Biol (2005) 1.81
Sequence-specific DNA binding by p53: identification of target sites and lack of binding to p53 - MDM2 complexes. EMBO J (1993) 1.77
Alternative and aberrant splicing of MDM2 mRNA in human cancer. Cancer Cell (2002) 1.70
Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer. Nat Med (1996) 1.68
Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc Natl Acad Sci U S A (1994) 1.53
Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4. Cancer Res (2006) 1.47
An alternative splice form of Mdm2 induces p53-independent cell growth and tumorigenesis. J Biol Chem (2003) 1.34
Qualitative and quantitative aspects of intercalator-induced DNA strand breaks. Biochim Biophys Acta (1979) 1.34
Dynamics in the p53-Mdm2 ubiquitination pathway. Cell Cycle (2004) 1.33
CP110 cooperates with two calcium-binding proteins to regulate cytokinesis and genome stability. Mol Biol Cell (2006) 1.27
Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer. Cancer Res (2001) 1.25
Actinomycin D inhibits human immunodeficiency virus type 1 minus-strand transfer in in vitro and endogenous reverse transcriptase assays. J Virol (1998) 1.21
Tumor promotion by Mdm2 splice variants unable to bind p53. Cancer Res (2003) 1.17
Unlocking the Mdm2-p53 loop: ubiquitin is the key. Cell Cycle (2007) 1.16
MDM2 transformation in the absence of p53 and abrogation of the p107 G1 cell-cycle arrest. Oncogene (1995) 1.08
Sequence-specific actinomycin D binding to single-stranded DNA inhibits HIV reverse transcriptase and other polymerases. Biochemistry (1996) 1.03
The mechanism of actinomycin D-mediated inhibition of HIV-1 reverse transcription. Nucleic Acids Res (1998) 0.96
Actinomycin D inhibition of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase and nucleocapsid protein. Biochemistry (1998) 0.92
mdm2 mRNA level is a prognostic factor in soft tissue sarcoma. Mol Med (2000) 0.85
Expression of alternatively and aberrantly spliced transcripts of the MDM2 mRNA is not tumor-specific. Int J Oncol (2004) 0.83
Mdm2 widens its repertoire. Cell Cycle (2007) 0.83
Actinomycin D binding to unstructured, single-stranded DNA. J Mol Recognit (2001) 0.82
Continuous induction of chromatid lesions by DNA-intercalating compounds. Mutat Res (1975) 0.81
Transferrin conjugates of adriamycin are cytotoxic without intercalating nuclear DNA. J Biol Chem (1992) 0.78
Relationships between physicochemical and biological properties in a series of oxazolopyridocarbazole derivatives (OPCd); comparison with related anti-tumor agents. Anticancer Drug Des (1988) 0.78
Inhibition of transcription by adriamycin is a consequence of the loss of negative superhelicity in DNA mediated by topoisomerase II. Mol Cell Biochem (1990) 0.76
p53--guardian of a genome's guardian? Cell Cycle (2003) 0.76
E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev (2002) 10.06
XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks. Mol Cell (2007) 4.93
An initial blueprint for myogenic differentiation. Genes Dev (2005) 4.22
A common set of gene regulatory networks links metabolism and growth inhibition. Mol Cell (2004) 3.37
Cep97 and CP110 suppress a cilia assembly program. Cell (2007) 3.15
E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes Dev (2002) 3.12
Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine. Nature (2012) 2.76
CP110, a cell cycle-dependent CDK substrate, regulates centrosome duplication in human cells. Dev Cell (2002) 2.74
Constructing transcriptional regulatory networks. Genes Dev (2005) 2.50
Genome-wide remodeling of the epigenetic landscape during myogenic differentiation. Proc Natl Acad Sci U S A (2011) 2.48
CP110 suppresses primary cilia formation through its interaction with CEP290, a protein deficient in human ciliary disease. Dev Cell (2008) 2.35
Centriolar kinesin Kif24 interacts with CP110 to remodel microtubules and regulate ciliogenesis. Cell (2011) 2.34
Emerging roles for E2F: beyond the G1/S transition and DNA replication. Cancer Cell (2003) 2.20
Hitting their targets: an emerging picture of E2F and cell cycle control. Curr Opin Genet Dev (2004) 2.01
USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110. Nature (2013) 1.94
Pocket protein complexes are recruited to distinct targets in quiescent and proliferating cells. Mol Cell Biol (2005) 1.81
Retinoblastoma tumor suppressor protein-dependent methylation of histone H3 lysine 27 is associated with irreversible cell cycle exit. J Cell Biol (2007) 1.72
New insights into cyclins, CDKs, and cell cycle control. Semin Cell Dev Biol (2005) 1.70
A role for mammalian Sin3 in permanent gene silencing. Mol Cell (2008) 1.59
E2F4 loss suppresses tumorigenesis in Rb mutant mice. Cancer Cell (2002) 1.48
Assembling a primary cilium. Curr Opin Cell Biol (2013) 1.45
alpha-Thrombin induces rapid and sustained Akt phosphorylation by beta-arrestin1-dependent and -independent mechanisms, and only the sustained Akt phosphorylation is essential for G1 phase progression. J Biol Chem (2002) 1.30
CP110 cooperates with two calcium-binding proteins to regulate cytokinesis and genome stability. Mol Biol Cell (2006) 1.27
SCAPER, a novel cyclin A-interacting protein that regulates cell cycle progression. J Cell Biol (2007) 1.17
E2f3b plays an essential role in myogenic differentiation through isoform-specific gene regulation. Genes Dev (2009) 1.07
The CP110-interacting proteins Talpid3 and Cep290 play overlapping and distinct roles in cilia assembly. J Cell Biol (2014) 1.06
Stimulation of the Raf/MEK/ERK cascade is necessary and sufficient for activation and Thr-160 phosphorylation of a nuclear-targeted CDK2. J Biol Chem (2002) 1.05
A new lipase in regulating lipid mobilization: hormone-sensitive lipase is not alone. Trends Endocrinol Metab (2005) 1.04
Reverse mutational analysis reveals threonine-373 as a potentially sufficient phosphorylation site for inactivation of the retinoblastoma tumor suppressor protein (pRB). Cell Cycle (2006) 1.01
Alpha-thrombin-mediated phosphatidylinositol 3-kinase activation through release of Gbetagamma dimers from Galphaq and Galphai2. J Biol Chem (2003) 0.97
Receptor type protein tyrosine phosphatase-kappa mediates cross-talk between transforming growth factor-beta and epidermal growth factor receptor signaling pathways in human keratinocytes. Mol Biol Cell (2009) 0.97
Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression. J Biol Chem (2003) 0.92
Cyclin A-CDK activity during G1 phase impairs MCM chromatin loading and inhibits DNA synthesis in mammalian cells. Cell Cycle (2008) 0.91
Activation of Cdk2/Cyclin E complexes is dependent on the origin of replication licensing factor Cdc6 in mammalian cells. Cell Cycle (2010) 0.90
Zinc induces ERK-dependent cell death through a specific Ras isoform. Apoptosis (2006) 0.90
The extreme COOH terminus of the retinoblastoma tumor suppressor protein pRb is required for phosphorylation on Thr-373 and activation of E2F. Am J Physiol Cell Physiol (2008) 0.89
Effect of α4β7 blockade on intestinal lymphocyte subsets and lymphoid tissue development. Inflamm Bowel Dis (2010) 0.83
Epithelial expression of the cytosolic retinoid chaperone cellular retinol binding protein II is essential for in vivo imprinting of local gut dendritic cells by lumenal retinoids. Am J Pathol (2012) 0.83
A novel mechanism for mitogen-activated protein kinase localization. Mol Biol Cell (2004) 0.81
Phosphatidylinositol 3-kinase regulates macrophage responses to double-stranded RNA and encephalomyocarditis virus. J Innate Immun (2009) 0.81
Double identity of SCAPER: a substrate and regulator of cyclin A/Cdk2. Cell Cycle (2008) 0.79
RNA interference takes flight: a new RNAi screen reveals cell cycle regulators in Drosophila cells. Trends Endocrinol Metab (2006) 0.79
Killing two birds with one RKIP. Trends Endocrinol Metab (2004) 0.79
beta-Arrestin 1 couples thrombin to the rapid activation of the Akt pathway. Ann N Y Acad Sci (2002) 0.79
The ethanol metabolite, linolenic acid ethyl ester, stimulates mitogen-activated protein kinase and cyclin signaling in hepatic stellate cells. Life Sci (2003) 0.79
CDK2 and cyclin E knockout mice: lessons from breast cancer. Trends Endocrinol Metab (2003) 0.78
A novel role for Gq alpha in alpha-thrombin-mediated mitogenic signalling pathways. Cell Signal (2002) 0.78
Loss of H2A.Z Is Not Sufficient to Determine Transcriptional Activity of Snf2-Related CBP Activator Protein or p400 Complexes. Int J Cell Biol (2011) 0.78
The rapid activation of N-Ras by alpha-thrombin in fibroblasts is mediated by the specific G-protein Galphai2-Gbeta1-Ggamma5 and occurs in lipid rafts. Cell Signal (2009) 0.77
More than scratching the surface: mitogen receptors as transcription factors? Trends Endocrinol Metab (2002) 0.76
sSgo1, a guardian of centriole cohesion. Dev Cell (2008) 0.76
Activation and phosphorylation on Thr-160 of nuclear-targeted CDK2 Is ERK dependent. Ann N Y Acad Sci (2002) 0.75
alpha-Thrombin activates Akt via a nonreceptor tyrosine kinase in IIC9 cells. Ann N Y Acad Sci (2002) 0.75